Parse Biosciences

Healthcare & Life Sciences

Recent Finacing

Hybrid C

Recent Raise

$50M

Parse Biosciences is a company that develops and commercializes scalable single-cell sequencing technologies for use in over 1,000 labs globally, aiming to expand its product range and market presence with its recent $50 million funding.